Showing results (281-290 of 436) with videos related to
Sort By:
Pageof 44
Immunity|January 25, 2011
Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathwaysManfred Nairz, Andrea Schroll, Alexander R Moschen, et al.Frontiers in Endocrinology|April 13, 2026
Escherichia-Shigella expansion and metabolite dysregulation in type 3c diabetes: linking microbiome alterations to exocrine pancreatic insufficiencyErika Kvalem Soto, Valeria Wagner, Julia Engl, et al.The Journal of Experimental Medicine|August 10, 2005
Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cellsStephanie K Dougan, Azucena Salas, Paul Rava, et al.Frontiers in Surgery|December 6, 2021
Reassessment of Relevance and Predictive Value of Parameters Indicating Early Graft Dysfunction in Liver Transplantation: AST Is a Weak, but Bilirubin and INR Strong Predictors of MortalityMargot Fodor, Adriana Woerdehoff, Wolfgang Peter, et al.Gut Microbes|July 5, 2022
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver diseaseMoris Sangineto, Christoph Grander, Felix Grabherr, et al.Gut|November 19, 2017
Gut roundtable meeting paper: selected recent advances in hepatocellular carcinomaAlexander Gerbes, Fabien Zoulim, Herbert Tilg, et al.European Radiology|August 5, 2020
Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA studyFabian Steinkohl, Fabian Barbieri, Thomas Senoner, et al.Hepatology (Baltimore, Md.)|March 8, 2011
Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosisAlexander R Moschen, Teresa Fritz, Andrew D Clouston, et al.Annals of Nuclear Medicine|March 29, 2017
Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paragangliomaAlexander Stephan Kroiss, Christian Uprimny, Barry Lynn Shulkin, et al.Biomedicines|November 26, 2022
Imaging Properties and Tumor Targeting of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST PatientsLeonhard Gruber, Clemens Decristoforo, Christian Uprimny, et al.Pageof 44